Magdalena M Szewczyk
Magdalena M Szewczyk
1Structural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7 Canada
1,
Yoshinori Ishikawa
Yoshinori Ishikawa
2Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555 Japan
2,#,
Shawna Organ
Shawna Organ
1Structural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7 Canada
1,#,
Nozomu Sakai
Nozomu Sakai
2Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555 Japan
2,#,
Fengling Li
Fengling Li
1Structural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7 Canada
1,#,
Levon Halabelian
Levon Halabelian
1Structural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7 Canada
1,
Suzanne Ackloo
Suzanne Ackloo
1Structural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7 Canada
1,
Amber L Couzens
Amber L Couzens
3Network Biology Collaborative Centre at the Lunenfeld-Tanenbaum Research Institute, 600 University Ave, Room 992, Toronto, ON M5G 1X5 Canada
3,
Mohammad Eram
Mohammad Eram
1Structural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7 Canada
1,
David Dilworth
David Dilworth
1Structural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7 Canada
1,
Hideto Fukushi
Hideto Fukushi
2Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555 Japan
2,
Rachel Harding
Rachel Harding
1Structural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7 Canada
1,
Carlo C dela Seña
Carlo C dela Seña
1Structural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7 Canada
1,
Tsukasa Sugo
Tsukasa Sugo
2Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555 Japan
2,
Kozo Hayashi
Kozo Hayashi
2Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555 Japan
2,
David McLeod
David McLeod
4Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, ON Canada
4,
Carlos Zepeda
Carlos Zepeda
4Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, ON Canada
4,
Ahmed Aman
Ahmed Aman
4Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, ON Canada
4,
Maria Sánchez-Osuna
Maria Sánchez-Osuna
5Institute for Research in Immunology and Cancer (IRIC) University of Montreal, 2950 Chemin de Polytechnique, Montreal, QC H3T 1J4 Canada
5,
Eric Bonneil
Eric Bonneil
5Institute for Research in Immunology and Cancer (IRIC) University of Montreal, 2950 Chemin de Polytechnique, Montreal, QC H3T 1J4 Canada
5,
Shinji Takagi
Shinji Takagi
2Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555 Japan
2,
Rima Al-Awar
Rima Al-Awar
4Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, ON Canada
6Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON M5S 1A8 Canada
4,6,
Mike Tyers
Mike Tyers
5Institute for Research in Immunology and Cancer (IRIC) University of Montreal, 2950 Chemin de Polytechnique, Montreal, QC H3T 1J4 Canada
5,
Stephane Richard
Stephane Richard
7Terry Fox Molecular Oncology Group and Bloomfield Center for Research on Aging, Lady Davis Institute for Medical Research and Departments of Oncology and Medicine, McGill University, Montreal, QC H3T 1E2 Canada
7,
Masayuki Takizawa
Masayuki Takizawa
2Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555 Japan
2,
Anne-Claude Gingras
Anne-Claude Gingras
3Network Biology Collaborative Centre at the Lunenfeld-Tanenbaum Research Institute, 600 University Ave, Room 992, Toronto, ON M5G 1X5 Canada
3,
Cheryl H Arrowsmith
Cheryl H Arrowsmith
1Structural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7 Canada
8Princess Margaret Cancer Centre and Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 2M9 Canada
1,8,
Masoud Vedadi
Masoud Vedadi
1Structural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7 Canada
6Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON M5S 1A8 Canada
1,6,
Peter J Brown
Peter J Brown
1Structural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7 Canada
1,
Hiroshi Nara
Hiroshi Nara
2Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555 Japan
2,✉,
Dalia Barsyte-Lovejoy
Dalia Barsyte-Lovejoy
1Structural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7 Canada
6Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON M5S 1A8 Canada
9Nature Research Center, Vilnius, Akademijos 2, Lithuania
1,6,9,✉
1Structural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7 Canada
2Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555 Japan
3Network Biology Collaborative Centre at the Lunenfeld-Tanenbaum Research Institute, 600 University Ave, Room 992, Toronto, ON M5G 1X5 Canada
4Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, ON Canada
5Institute for Research in Immunology and Cancer (IRIC) University of Montreal, 2950 Chemin de Polytechnique, Montreal, QC H3T 1J4 Canada
6Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON M5S 1A8 Canada
7Terry Fox Molecular Oncology Group and Bloomfield Center for Research on Aging, Lady Davis Institute for Medical Research and Departments of Oncology and Medicine, McGill University, Montreal, QC H3T 1E2 Canada
8Princess Margaret Cancer Centre and Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 2M9 Canada
9Nature Research Center, Vilnius, Akademijos 2, Lithuania
Subject terms: Transferases, Stress signalling, Methylation, Target validation
© The Author(s) 2020
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
